SHR-1918 for homozygous familial hypercholesterolemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Aug 2025: Trial registered, NCT07133815

The trials

NCT07133815: Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

State
Not started
Phase
Phase 2
People
55 planned
Started
Aug 2025
Primary completion
Dec 2025
Arms
SHR-1918
Results
None posted
  1. 21 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.